Aeromics
PrivateLast Round
Strategic
Nov 5, 2019
Total Funding Raised
$14.08M
Company Overview
Aeromics is a pharmaceutical company that develops anti-edema therapies designed to treat patients affected by acute central nervous system edema.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aeromics Comparables
Compare Aeromics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedy Pharmaceuticals | 89% | |
| Egret Therapeutics | 78% | |
| Simcere Pharmaceutical Group | 76% |
Aeromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 5, 2019 | ||||
| VC Round | Jun 19, 2018 | ||||
| Series A | Sep 20, 2017 | ||||
| Seed | Apr 6, 2016 | ||||
| Seed | Mar 6, 2014 | ||||
Grant | Feb 24, 2012 |
Aeromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | VC Round, Series A, Seed |
| NIH RADx | Grant |
| Broadview Ventures | VC Round, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors grew 33% MoM.
- Jun 1, 2025
Monthly visitors increased 72% MoM, reaching 1.4K.
Aeromics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aeromics's valuation, stock price, and market status.
Is Aeromics a public or private company?
Aeromics is a private company.
What is the current stock price of Aeromics?
Aeromics is a private company, so its shares have no public market price. Caplight tracks Aeromics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aeromics worth (valuation)?
Valuation information for Aeromics is not publicly available.
Can I buy Aeromics stock?
Aeromics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aeromics's last funding round?
Aeromics's most recent funding round was Strategic on November 5, 2019.
Who are the main investors in Aeromics?
Key investors in Aeromics include Broadview Ventures.
Will Aeromics IPO soon?
No public IPO plans have been announced for Aeromics.
How can I track Aeromics secondary market activity?
Caplight tracks bids, offers, and trades in Aeromics's shares on secondary markets.